社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
CWTeoh
IP属地:未知
+关注
帖子 · 20
帖子 · 20
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
CWTeoh
CWTeoh
·
2021-08-25
Buy
@joechill:
$ContextLogic Inc.(WISH)$hmmm
$ContextLogic Inc.(WISH)$hmmm
看
454
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-08-25
$ContextLogic Inc.(WISH)$
buy
看
568
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-08-14
$ContextLogic Inc.(WISH)$
buy
看
860
回复
2
点赞
6
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-07-10
Buy
非常抱歉,此主贴已删除
看
682
回复
评论
点赞
3
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-07-02
Buy
一图看懂康诺亚-B(2162.HK)IPO
@格隆汇:
康诺亚-B(2162.HK)于2021年6月25日-6月30日招股,公司拟全球发售5826.45万股,其中香港发售582.70万股,国际发售5243.75万股,另有15%超额配股权;招股价区间为50.5港元-53.3港元,每手买卖单位500股,入场费约2.69万港元;摩根士丹利、中金公司及华泰国际为联席保荐人;预计6月30日定价、7月8日挂牌。
一图看懂康诺亚-B(2162.HK)IPO
看
401
回复
评论
点赞
1
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-06-24
Great ariticle, would you like to share it?
港股收评:三大指数震荡收涨 烟草概念股表现强势
@格隆汇:
6月24日,港股三大指数全天呈窄幅震荡走势,恒指涨0.23%报28882.46点,国指跌0.03%报10677.31点,恒生科技指数涨0.24%报8039.76点。盘面上,烟草概念股表现强势,华宝国际、中国波顿均大涨超11%;教育股全线反弹,物管股继续大涨,滨江服务、世茂服务均创历史新高;生物医药股持续活跃,开拓药业、康宁杰瑞均大涨9%;汽车股、石油股、电信股普涨;大型科技股美团涨超2%,百度、阿里巴巴涨超1%,惟快手跌4%;前期强势的体育用品股、港口航运股全线回调,半导体股、医美股、燃气股走低明显。今日大市成交额为1339亿港元,南下资金净流入29.47亿港元。具体来看电子烟概念股集体走强,华宝国际、中国波顿涨超11%,思摩尔国际涨近6%,比亚迪电子微涨。华创证券最新发布的研报称,国内电子烟市场短期面临监管风险,但预计长期快速增长趋势不改,监管规范更利于头部企业,维持思摩尔国际“强推”评级。中金最新研报称,思摩尔国际核心竞争力突出,已在陶瓷芯领域建立完备专利保护体系,新进入者规避难度较大;此外,优质的客户优势,以及美国PMTA等监管壁垒,使公司能够高效配合客户进行新品开发;维持思摩尔国际74港元的目标价。物管股继续走强普涨,绿城管理控股涨超10%,时代邻里、滨江服务涨超7%,华润万象生活涨超6%,世茂服务、恒大物业涨超3%。摩通近日发研报指,料内地物管股至8月初将有约20%的股价上升空间,并料在7月期间各物管股将接连公布盈喜,推动板块股价上升。该行预计,于其追踪的15间物管公司中,有10间将公布盈喜,上半年行业平均盈利增长可达57%。物管股板块中,该行首选世茂服务、金科服务、融创服务及永升生活服务,均由首二十大房地产企业所支持,相信将公布盈喜或收购,刺激股价向上。该行上调融创服务评级至“增持”,并首予恒大物业“增持”评级。苹果概念股涨幅居前,通达集团涨超12%,高伟电子涨
港股收评:三大指数震荡收涨 烟草概念股表现强势
看
473
回复
评论
点赞
1
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-06-22
$ContextLogic Inc.(WISH)$
gogogo
看
500
回复
评论
点赞
2
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-06-22
Woo
非常抱歉,此主贴已删除
看
549
回复
1
点赞
5
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-06-22
Aem
非常抱歉,此主贴已删除
看
395
回复
评论
点赞
5
编组 21备份 2
分享
举报
CWTeoh
CWTeoh
·
2021-06-22
Buy
再获进展!加科思-BSHP2 抑制剂两项联合用药临床试验完成首例患者给药
@港股研究社:
港股研究社获悉,加科思-B 公布,公司加科思$加科思-B(01167)$ 在研的 SHP2 抑制剂 JAB-3312 与帕博利珠单抗 (Pembrolizumab) 及贝美替尼 (Binimetinib) 的联合用药临床试验,已分别在美国完成首例两名患者给药,这是一项针对治疗晚期实体瘤患者的 1/2a 期临床试验。根据双方于 2020 年 5 月签订的许可及合作协议,这项临床进展将触发公司与艾伯维 (AbbVie) 合作的里程碑付款条件,根据许可协议,公司将收到艾伯维 2000 万美元的里程碑付款。根据许可协议中有关2020年9月已行使的在中国大陆、香港和澳门独家开发和商业化SHP2抑制剂的选择权,公司已授予AbbVie研究、开发、制造、商业化和以其他方式利用SHP2抑制剂的全球、独家、可再许可的许可。由于中国选择权已被行使,在有限的例外情况下,公司拥有开发、商业化和生产此类SHP2抑制剂产品的独家权利(甚至对于艾伯维及其附属公司),以寻求监管部门在相关地区内批准和商业化此类SHP2抑制剂。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们
再获进展!加科思-BSHP2 抑制剂两项联合用药临床试验完成首例患者给药
看
650
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3574398927411972","uuid":"3574398927411972","gmtCreate":1611380187442,"gmtModify":1615619589929,"name":"CWTeoh","pinyin":"cwteoh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":54,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":837251687,"gmtCreate":1629896009649,"gmtModify":1631889763445,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837251687","repostId":"837280471","repostType":1,"repost":{"id":837280471,"gmtCreate":1629893400693,"gmtModify":1631883751795,"author":{"id":"3575808212091665","authorId":"3575808212091665","name":"joechill","avatar":"https://static.tigerbbs.com/2f2d8cb6ee2d0d6e3f378e806e934ec0","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575808212091665","authorIdStr":"3575808212091665"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>hmmm","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>hmmm","text":"$ContextLogic Inc.(WISH)$hmmm","images":[{"img":"https://static.tigerbbs.com/6ef7ba26e7ecf95c82f8f16fc0391fff","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837280471","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837251930,"gmtCreate":1629895957420,"gmtModify":1631883751793,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>buy","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>buy","text":"$ContextLogic Inc.(WISH)$buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837251930","isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897273612,"gmtCreate":1628931081836,"gmtModify":1631883867517,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>buy","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>buy","text":"$ContextLogic Inc.(WISH)$buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897273612","isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141775399,"gmtCreate":1625895939211,"gmtModify":1631889763455,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/141775399","repostId":"2150306047","repostType":4,"isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156559745,"gmtCreate":1625231945687,"gmtModify":1631889763468,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/156559745","repostId":"156668350","repostType":1,"repost":{"id":156668350,"gmtCreate":1625218826070,"gmtModify":1625218826070,"author":{"id":"39105730803552","authorId":"39105730803552","name":"格隆汇","avatar":"https://static.tigerbbs.com/8774dfe20eceb38c9645128bb6e60684","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"39105730803552","authorIdStr":"39105730803552"},"themes":[],"title":"一图看懂康诺亚-B(2162.HK)IPO","htmlText":"康诺亚-B(2162.HK)于2021年6月25日-6月30日招股,公司拟全球发售5826.45万股,其中香港发售582.70万股,国际发售5243.75万股,另有15%超额配股权;招股价区间为50.5港元-53.3港元,每手买卖单位500股,入场费约2.69万港元;摩根士丹利、中金公司及华泰国际为联席保荐人;预计6月30日定价、7月8日挂牌。","listText":"康诺亚-B(2162.HK)于2021年6月25日-6月30日招股,公司拟全球发售5826.45万股,其中香港发售582.70万股,国际发售5243.75万股,另有15%超额配股权;招股价区间为50.5港元-53.3港元,每手买卖单位500股,入场费约2.69万港元;摩根士丹利、中金公司及华泰国际为联席保荐人;预计6月30日定价、7月8日挂牌。","text":"康诺亚-B(2162.HK)于2021年6月25日-6月30日招股,公司拟全球发售5826.45万股,其中香港发售582.70万股,国际发售5243.75万股,另有15%超额配股权;招股价区间为50.5港元-53.3港元,每手买卖单位500股,入场费约2.69万港元;摩根士丹利、中金公司及华泰国际为联席保荐人;预计6月30日定价、7月8日挂牌。","images":[{"img":"https://static.tigerbbs.com/b93ee549fa584bba5cf096f0bc8e594b","width":"681","height":"10000"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/156668350","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128455455,"gmtCreate":1624528901577,"gmtModify":1631889763477,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128455455","repostId":"128402594","repostType":1,"repost":{"id":128402594,"gmtCreate":1624526160118,"gmtModify":1624526160118,"author":{"id":"39105730803552","authorId":"39105730803552","name":"格隆汇","avatar":"https://static.tigerbbs.com/8774dfe20eceb38c9645128bb6e60684","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"39105730803552","authorIdStr":"39105730803552"},"themes":[],"title":"港股收评:三大指数震荡收涨 烟草概念股表现强势","htmlText":"6月24日,港股三大指数全天呈窄幅震荡走势,恒指涨0.23%报28882.46点,国指跌0.03%报10677.31点,恒生科技指数涨0.24%报8039.76点。盘面上,烟草概念股表现强势,华宝国际、中国波顿均大涨超11%;教育股全线反弹,物管股继续大涨,滨江服务、世茂服务均创历史新高;生物医药股持续活跃,开拓药业、康宁杰瑞均大涨9%;汽车股、石油股、电信股普涨;大型科技股美团涨超2%,百度、阿里巴巴涨超1%,惟快手跌4%;前期强势的体育用品股、港口航运股全线回调,半导体股、医美股、燃气股走低明显。今日大市成交额为1339亿港元,南下资金净流入29.47亿港元。具体来看电子烟概念股集体走强,华宝国际、中国波顿涨超11%,思摩尔国际涨近6%,比亚迪电子微涨。华创证券最新发布的研报称,国内电子烟市场短期面临监管风险,但预计长期快速增长趋势不改,监管规范更利于头部企业,维持思摩尔国际“强推”评级。中金最新研报称,思摩尔国际核心竞争力突出,已在陶瓷芯领域建立完备专利保护体系,新进入者规避难度较大;此外,优质的客户优势,以及美国PMTA等监管壁垒,使公司能够高效配合客户进行新品开发;维持思摩尔国际74港元的目标价。物管股继续走强普涨,绿城管理控股涨超10%,时代邻里、滨江服务涨超7%,华润万象生活涨超6%,世茂服务、恒大物业涨超3%。摩通近日发研报指,料内地物管股至8月初将有约20%的股价上升空间,并料在7月期间各物管股将接连公布盈喜,推动板块股价上升。该行预计,于其追踪的15间物管公司中,有10间将公布盈喜,上半年行业平均盈利增长可达57%。物管股板块中,该行首选世茂服务、金科服务、融创服务及永升生活服务,均由首二十大房地产企业所支持,相信将公布盈喜或收购,刺激股价向上。该行上调融创服务评级至“增持”,并首予恒大物业“增持”评级。苹果概念股涨幅居前,通达集团涨超12%,高伟电子涨","listText":"6月24日,港股三大指数全天呈窄幅震荡走势,恒指涨0.23%报28882.46点,国指跌0.03%报10677.31点,恒生科技指数涨0.24%报8039.76点。盘面上,烟草概念股表现强势,华宝国际、中国波顿均大涨超11%;教育股全线反弹,物管股继续大涨,滨江服务、世茂服务均创历史新高;生物医药股持续活跃,开拓药业、康宁杰瑞均大涨9%;汽车股、石油股、电信股普涨;大型科技股美团涨超2%,百度、阿里巴巴涨超1%,惟快手跌4%;前期强势的体育用品股、港口航运股全线回调,半导体股、医美股、燃气股走低明显。今日大市成交额为1339亿港元,南下资金净流入29.47亿港元。具体来看电子烟概念股集体走强,华宝国际、中国波顿涨超11%,思摩尔国际涨近6%,比亚迪电子微涨。华创证券最新发布的研报称,国内电子烟市场短期面临监管风险,但预计长期快速增长趋势不改,监管规范更利于头部企业,维持思摩尔国际“强推”评级。中金最新研报称,思摩尔国际核心竞争力突出,已在陶瓷芯领域建立完备专利保护体系,新进入者规避难度较大;此外,优质的客户优势,以及美国PMTA等监管壁垒,使公司能够高效配合客户进行新品开发;维持思摩尔国际74港元的目标价。物管股继续走强普涨,绿城管理控股涨超10%,时代邻里、滨江服务涨超7%,华润万象生活涨超6%,世茂服务、恒大物业涨超3%。摩通近日发研报指,料内地物管股至8月初将有约20%的股价上升空间,并料在7月期间各物管股将接连公布盈喜,推动板块股价上升。该行预计,于其追踪的15间物管公司中,有10间将公布盈喜,上半年行业平均盈利增长可达57%。物管股板块中,该行首选世茂服务、金科服务、融创服务及永升生活服务,均由首二十大房地产企业所支持,相信将公布盈喜或收购,刺激股价向上。该行上调融创服务评级至“增持”,并首予恒大物业“增持”评级。苹果概念股涨幅居前,通达集团涨超12%,高伟电子涨","text":"6月24日,港股三大指数全天呈窄幅震荡走势,恒指涨0.23%报28882.46点,国指跌0.03%报10677.31点,恒生科技指数涨0.24%报8039.76点。盘面上,烟草概念股表现强势,华宝国际、中国波顿均大涨超11%;教育股全线反弹,物管股继续大涨,滨江服务、世茂服务均创历史新高;生物医药股持续活跃,开拓药业、康宁杰瑞均大涨9%;汽车股、石油股、电信股普涨;大型科技股美团涨超2%,百度、阿里巴巴涨超1%,惟快手跌4%;前期强势的体育用品股、港口航运股全线回调,半导体股、医美股、燃气股走低明显。今日大市成交额为1339亿港元,南下资金净流入29.47亿港元。具体来看电子烟概念股集体走强,华宝国际、中国波顿涨超11%,思摩尔国际涨近6%,比亚迪电子微涨。华创证券最新发布的研报称,国内电子烟市场短期面临监管风险,但预计长期快速增长趋势不改,监管规范更利于头部企业,维持思摩尔国际“强推”评级。中金最新研报称,思摩尔国际核心竞争力突出,已在陶瓷芯领域建立完备专利保护体系,新进入者规避难度较大;此外,优质的客户优势,以及美国PMTA等监管壁垒,使公司能够高效配合客户进行新品开发;维持思摩尔国际74港元的目标价。物管股继续走强普涨,绿城管理控股涨超10%,时代邻里、滨江服务涨超7%,华润万象生活涨超6%,世茂服务、恒大物业涨超3%。摩通近日发研报指,料内地物管股至8月初将有约20%的股价上升空间,并料在7月期间各物管股将接连公布盈喜,推动板块股价上升。该行预计,于其追踪的15间物管公司中,有10间将公布盈喜,上半年行业平均盈利增长可达57%。物管股板块中,该行首选世茂服务、金科服务、融创服务及永升生活服务,均由首二十大房地产企业所支持,相信将公布盈喜或收购,刺激股价向上。该行上调融创服务评级至“增持”,并首予恒大物业“增持”评级。苹果概念股涨幅居前,通达集团涨超12%,高伟电子涨","images":[{"img":"https://static.tigerbbs.com/58f53679b0619397d1dea54e7568e683","width":"688","height":"256"},{"img":"https://static.tigerbbs.com/0803a85c33b8d8bfceeaadf6e59c44a8","width":"475","height":"105"},{"img":"https://static.tigerbbs.com/507167b388d49a2085fcc98ff1214c9a","width":"495","height":"125"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128402594","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":16,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129165503,"gmtCreate":1624365711402,"gmtModify":1631889763490,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","text":"$ContextLogic Inc.(WISH)$gogogo","images":[{"img":"https://static.tigerbbs.com/ae53d6c36e76973a74d303c7b957c7ad","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/129165503","isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":129041752,"gmtCreate":1624347652076,"gmtModify":1631889763506,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Woo","listText":"Woo","text":"Woo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129041752","repostId":"2145032477","repostType":4,"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129043451,"gmtCreate":1624347578773,"gmtModify":1631889763511,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Aem","listText":"Aem","text":"Aem","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/129043451","repostId":"2145053984","repostType":4,"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120745457,"gmtCreate":1624339962379,"gmtModify":1631889763521,"author":{"id":"3574398927411972","authorId":"3574398927411972","name":"CWTeoh","avatar":"https://static.tigerbbs.com/0fe81add843fc724a281b0eb5ca903e1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574398927411972","authorIdStr":"3574398927411972"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120745457","repostId":"168426486","repostType":1,"repost":{"id":168426486,"gmtCreate":1623981473345,"gmtModify":1623984778687,"author":{"id":"3516422794850265","authorId":"3516422794850265","name":"港股研究社","avatar":"https://static.tigerbbs.com/6f93253ece299c58b5ce6c809885d9ed","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516422794850265","authorIdStr":"3516422794850265"},"themes":[],"title":"再获进展!加科思-BSHP2 抑制剂两项联合用药临床试验完成首例患者给药","htmlText":"港股研究社获悉,加科思-B 公布,公司加科思<a target=\"_blank\" href=\"https://laohu8.com/S/01167\">$加科思-B(01167)$</a> 在研的 SHP2 抑制剂 JAB-3312 与帕博利珠单抗 (Pembrolizumab) 及贝美替尼 (Binimetinib) 的联合用药临床试验,已分别在美国完成首例两名患者给药,这是一项针对治疗晚期实体瘤患者的 1/2a 期临床试验。根据双方于 2020 年 5 月签订的许可及合作协议,这项临床进展将触发公司与艾伯维 (AbbVie) 合作的里程碑付款条件,根据许可协议,公司将收到艾伯维 2000 万美元的里程碑付款。根据许可协议中有关2020年9月已行使的在中国大陆、香港和澳门独家开发和商业化SHP2抑制剂的选择权,公司已授予AbbVie研究、开发、制造、商业化和以其他方式利用SHP2抑制剂的全球、独家、可再许可的许可。由于中国选择权已被行使,在有限的例外情况下,公司拥有开发、商业化和生产此类SHP2抑制剂产品的独家权利(甚至对于艾伯维及其附属公司),以寻求监管部门在相关地区内批准和商业化此类SHP2抑制剂。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","listText":"港股研究社获悉,加科思-B 公布,公司加科思<a target=\"_blank\" href=\"https://laohu8.com/S/01167\">$加科思-B(01167)$</a> 在研的 SHP2 抑制剂 JAB-3312 与帕博利珠单抗 (Pembrolizumab) 及贝美替尼 (Binimetinib) 的联合用药临床试验,已分别在美国完成首例两名患者给药,这是一项针对治疗晚期实体瘤患者的 1/2a 期临床试验。根据双方于 2020 年 5 月签订的许可及合作协议,这项临床进展将触发公司与艾伯维 (AbbVie) 合作的里程碑付款条件,根据许可协议,公司将收到艾伯维 2000 万美元的里程碑付款。根据许可协议中有关2020年9月已行使的在中国大陆、香港和澳门独家开发和商业化SHP2抑制剂的选择权,公司已授予AbbVie研究、开发、制造、商业化和以其他方式利用SHP2抑制剂的全球、独家、可再许可的许可。由于中国选择权已被行使,在有限的例外情况下,公司拥有开发、商业化和生产此类SHP2抑制剂产品的独家权利(甚至对于艾伯维及其附属公司),以寻求监管部门在相关地区内批准和商业化此类SHP2抑制剂。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","text":"港股研究社获悉,加科思-B 公布,公司加科思$加科思-B(01167)$ 在研的 SHP2 抑制剂 JAB-3312 与帕博利珠单抗 (Pembrolizumab) 及贝美替尼 (Binimetinib) 的联合用药临床试验,已分别在美国完成首例两名患者给药,这是一项针对治疗晚期实体瘤患者的 1/2a 期临床试验。根据双方于 2020 年 5 月签订的许可及合作协议,这项临床进展将触发公司与艾伯维 (AbbVie) 合作的里程碑付款条件,根据许可协议,公司将收到艾伯维 2000 万美元的里程碑付款。根据许可协议中有关2020年9月已行使的在中国大陆、香港和澳门独家开发和商业化SHP2抑制剂的选择权,公司已授予AbbVie研究、开发、制造、商业化和以其他方式利用SHP2抑制剂的全球、独家、可再许可的许可。由于中国选择权已被行使,在有限的例外情况下,公司拥有开发、商业化和生产此类SHP2抑制剂产品的独家权利(甚至对于艾伯维及其附属公司),以寻求监管部门在相关地区内批准和商业化此类SHP2抑制剂。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","images":[{"img":"https://static.tigerbbs.com/02d7c874e362fc66a5b67008e4591080","width":"602","height":"300"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168426486","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":650,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}